These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31500062)

  • 61. Nanodroplets Engineered with Folate Carbon Dots for Enhanced Cancer Cell Uptake toward Theranostic Application.
    Kumawat A; Saini B; Ghoroi C
    ACS Appl Bio Mater; 2024 Aug; 7(8):5483-5495. PubMed ID: 39046462
    [TBL] [Abstract][Full Text] [Related]  

  • 62. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
    Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
    Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multi-functional core-shell Fe
    S R; M P
    Colloids Surf B Biointerfaces; 2019 Feb; 174():252-259. PubMed ID: 30469046
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro evaluation of doxorubicin-incorporated magnetic albumin nanospheres.
    Zeybek A; Şanlı-Mohamed G; Ak G; Yılmaz H; Şanlıer ŞH
    Chem Biol Drug Des; 2014 Jul; 84(1):108-15. PubMed ID: 24524300
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
    Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects.
    Gao F; Li L; Liu T; Hao N; Liu H; Tan L; Li H; Huang X; Peng B; Yan C; Yang L; Wu X; Chen D; Tang F
    Nanoscale; 2012 Jun; 4(11):3365-72. PubMed ID: 22538830
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
    Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Smart Carriers for Controlled Drug Delivery: Thermosensitive Polymers Embedded in Ordered Mesoporous Carbon.
    Kiamahalleh MV; Mellati A; Madani SA; Pendleton P; Zhang H; Madani SH
    J Pharm Sci; 2017 Jun; 106(6):1545-1552. PubMed ID: 28238898
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
    Wu J; Jiang W; Shen Y; Jiang W; Tian R
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hydroxylated Mesoporous Nanosilica Coated by Polyethylenimine Coupled with Gadolinium and Folic Acid: A Tumor-Targeted T(1) Magnetic Resonance Contrast Agent and Drug Delivery System.
    Zhang G; Gao J; Qian J; Zhang L; Zheng K; Zhong K; Cai D; Zhang X; Wu Z
    ACS Appl Mater Interfaces; 2015 Jul; 7(26):14192-200. PubMed ID: 26084052
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ZnO capped flower-like porous carbon-Fe
    Yang Z; Wang L; Liu Y; Liu S; Tang D; Meng L; Cui B
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110256. PubMed ID: 31761234
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simultaneous linear release of folic acid and doxorubicin from ethyl cellulose/chitosan/g-C
    Nouri A; Faraji Dizaji B; Kianinejad N; Jafari Rad A; Rahimi S; Irani M; Sharifian Jazi F
    J Biomed Mater Res A; 2021 Jun; 109(6):903-914. PubMed ID: 32776414
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipid-coated hollow mesoporous silica nanospheres for co-delivery of doxorubicin and paclitaxel: Preparation, sustained release, cellular uptake and pharmacokinetics.
    Qiu Y; Wu C; Jiang J; Hao Y; Zhao Y; Xu J; Yu T; Ji P
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():835-843. PubMed ID: 27987779
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
    Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
    J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design and Fabrication of Multifunctional Sericin Nanoparticles for Tumor Targeting and pH-Responsive Subcellular Delivery of Cancer Chemotherapy Drugs.
    Huang L; Tao K; Liu J; Qi C; Xu L; Chang P; Gao J; Shuai X; Wang G; Wang Z; Wang L
    ACS Appl Mater Interfaces; 2016 Mar; 8(10):6577-85. PubMed ID: 26855027
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy.
    Zhao X; Jia X; Liu L; Zeng J; Tian K; Zhou T; Liu P
    Biomacromolecules; 2016 Apr; 17(4):1496-505. PubMed ID: 27010934
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multifunctional near infrared-emitting long-persistence luminescent nanoprobes for drug delivery and targeted tumor imaging.
    Shi J; Sun X; Li J; Man H; Shen J; Yu Y; Zhang H
    Biomaterials; 2015 Jan; 37():260-70. PubMed ID: 25453956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
    Mizusako H; Tagami T; Hattori K; Ozeki T
    J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.